Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

916 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of GM-CSF in the treatment of acute myeloid leukemia.
Büchner T, Hiddemann W, Wörmann B, Rottmann R, Maschmeyer G, Ludwig WD, Zühlsdorf M, Buntkirchen K, Sander A, Aswald J, et al. Büchner T, et al. Among authors: hiddemann w. Leuk Lymphoma. 1993;11 Suppl 2:21-4. doi: 10.3109/10428199309064257. Leuk Lymphoma. 1993. PMID: 8124228 Clinical Trial.
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
Braess J, Amler S, Kreuzer KA, Spiekermann K, Lindemann HW, Lengfelder E, Graeven U, Staib P, Ludwig WD, Biersack H, Ko YD, Uppenkamp MJ, De Wit M, Korsten S, Peceny R, Gaska T, Schiel X, Behringer DM, Kiehl MG, Zinngrebe B, Meckenstock G, Roemer E, Medgenberg D, Spaeth-Schwalbe E, Massenkeil G, Hindahl H, Schwerdtfeger R, Trenn G, Sauerland C, Koch R, Lablans M, Faldum A, Görlich D, Bohlander SK, Schneider S, Dufour A, Buske C, Fiegl M, Subklewe M, Braess B, Unterhalt M, Baumgartner A, Wörmann B, Beelen D, Hiddemann W; AML-CG. Braess J, et al. Among authors: hiddemann w. Leukemia. 2018 Dec;32(12):2558-2571. doi: 10.1038/s41375-018-0268-9. Epub 2018 Oct 1. Leukemia. 2018. PMID: 30275528 Free PMC article. Clinical Trial.
Acute myeloid leukemia: treatment over 60.
Büchner T, Hiddemann W, Berdel W, Wörmann B, Schoch C, Löffler H, Haferlach T, Schumacher A, Staib P, Balleisen L, Grüneisen A, Rasche H, Aul C, Heyll A, Lengfelder E, Ludwig WD, Maschmeyer G, Eimermacher H, Karow J, Frickhofen N, Hirschmann WD, Sauerland MC; German AML Co-Operative Group. Büchner T, et al. Among authors: hiddemann w. Rev Clin Exp Hematol. 2002 Mar;6(1):46-59; discussion 86-7. doi: 10.1046/j.1468-0734.2002.00059.x. Rev Clin Exp Hematol. 2002. PMID: 12060483 Review.
GM-CSF in the treatment of acute myeloid leukemia.
Hiddemann W, Maschmeyer G, Ludwig WD, Königsmann M, Zühlsdorf M, Wörmann B, Boeckmann A, Agion-Freire E, Innig G, Reuter C, et al. Hiddemann W, et al. Pathol Biol (Paris). 1992 Nov;39(9):959. Pathol Biol (Paris). 1992. PMID: 1538952 No abstract available.
In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
Wörmann B, Hiddemann W, Frisch J, Zühlsdorf M, Rottmann R, Boeckmann A, Reuter C, Freire EA, Innig G, Schulz G, et al. Wörmann B, et al. Among authors: hiddemann w. Behring Inst Mitt. 1991 Dec;(90):28-38. Behring Inst Mitt. 1991. PMID: 1801688 Clinical Trial.
916 results